Who owns SURF - SURFACE ONCOLOGY INC - COM based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

SURFACE ONCOLOGY INC - COM (SURF) Institutional Ownership

Q: What is CUSIP 86877M209?

CUSIP 86877M209 is the security identifier used in SEC filing datasets for SURF - SURFACE ONCOLOGY INC - COM.

CUSIP: 86877M209

13F Institutional Holders and Ownership History from Q2 2018 to Q3 2023

Type / Class: Equity / COM
Symbol: SURF

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 86877M209?
CUSIP 86877M209 identifies SURF - SURFACE ONCOLOGY INC - COM in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 86877M209:

Q3 2023 (0 holders) Q2 2023 (61 holders) Q1 2023 (69 holders) Q4 2022 (75 holders) Q3 2022 (70 holders) Q2 2022 (76 holders) Q1 2022 (97 holders) Q4 2021 (101 holders) Q3 2021 (88 holders) Q2 2021 (90 holders)

Institutional Holders of SURFACE ONCOLOGY INC - COM (SURF) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2023 Q3	0	$0	-$16,920,777	$0	$0		0
2023 Q2	19,454,610	$16,920,778	-$5,025,368	$17,392	$44,524	$0.87	61
2023 Q1	26,917,358	$18,763,275	-$1,169,602	$559	$2,096	$0.70	69
2022 Q4	28,557,874	$23,399,191	-$2,286,577	$5,822	$67,496	$0.82	75
2022 Q3	31,611,556	$32,828,491	+$2,352,023	$0	$85,000	$1.04	70
2022 Q2	28,909,514	$48,580,627	-$9,342,116	$47,000	$255,000	$1.64	76
2022 Q1	31,906,082	$93,791,793	+$17,408,404	$198,000	$270,000	$2.94	97
2021 Q4	24,671,179	$117,984,981	-$532,761	$582,000	$476,000	$4.78	101
2021 Q3	24,064,590	$182,115,210	+$11,239,253	$1,037,000	$2,416,000	$7.57	88
2021 Q2	19,637,085	$146,474,132	+$25,821,133	$2,341,000	$2,873,000	$7.46	90
2021 Q1	18,901,265	$147,428,800	-$16,819,020	$2,583,000	$1,753,000	$7.80	84
2020 Q4	23,084,333	$213,291,000	-$16,512,458	$1,984,000	$1,194,000	$9.24	88
2020 Q3	21,526,543	$148,527,000	-$3,059,637		$135,000	$6.90	57
2020 Q2	22,179,175	$145,495,026	+$75,907,429			$6.56	42
2020 Q1	13,660,266	$25,544,122	-$419,070			$1.87	27
2019 Q4	13,884,050	$26,099,149	-$1,518,800			$1.88	32
2019 Q3	14,723,513	$20,907,029	-$1,794,136			$1.42	34
2019 Q2	15,731,423	$44,361,030	-$2,563,472			$2.82	45
2019 Q1	16,435,408	$78,394,011	-$834,421			$4.77	54
2018 Q4	16,628,557	$70,503,547	-$7,225,464			$4.24	48
2018 Q3	17,463,111	$191,045,604	-$2,798,587			$10.94	43
2018 Q2	17,483,815	$285,158,000	+$285,158,000			$16.31	46